ARNI | Arno Therapeutics, Inc. Annual & Quarterly Cash

Annual Cash Flows

(In USD)

Breakdown	2022	2021	2020	2019	2015	2014
Operating Cash Flow	-	-	-	-	-9.96 Million	-18.8 Million
Net Income	-	-	-	-	-11.5 Million	7.77 Million
Depreciation & Amortization	-	-	-	-	7627.00	12.58 Thousand
Deferred income taxes	-	-	-	-	2437.00	-
Stock-based compensation	-	-	-	-	3.47 Million	4.52 Million
Change in working capital	-	-	-	-	-19.62 Thousand	-1.91 Million
Other non-cash items	-	-	-	-	-1.92 Million	-29.19 Million
Investing Cash Flow	-	-	-	-	-	-20.35 Thousand
Investments in PPE	-	-	-	-	-	-20.09 Thousand
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-255.00
Financing Cash Flow	-	-	-	-	2.08 Million	-255.00
Debt repayment	-	-	-	-	-3322.00	-255.00
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	-	-
Other Financing Activities	-	-	-	-	2.08 Million	-
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	267.76 Thousand	-2.19 Million
Inventory	-	-	-	-	-	-
Other working capital	-	-	-	-	-287.38 Thousand	280.47 Thousand
Cash at beginning of period	-	-	-	-	7.94 Million	26.77 Million
Cash at end of period	-	-	-	-	66.98 Thousand	7.94 Million
Capital Expenditure	-	-	-	-	-	-20.09 Thousand
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	-	-	-	-	-7.88 Million	-18.82 Million
Free Cash Flow	-	-	-	-	-9.96 Million	-18.82 Million

Breakdown	2022 FY	2021 FY	2020 FY	2019 FY	2016 Q3	2016 Q2
Operating Cash Flow	-	-	-	-	-	-
Net Income	-	-	-	-	-3.84 Million	-2.14 Million
Depreciation & Amortization	-	-	-	-	1801.00	1780.00
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	1.02 Million	1.01 Million
Change in working capital	-	-	-	-	-329.09 Thousand	565.55 Thousand
Other non-cash items	-	-	-	-	2.01 Million	-1.11 Million
Investing Cash Flow	-	-	-	-	-	-
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	-	-	-	-	2.32 Million	-66.69 Thousand
Debt repayment	-	-	-	-	-980.00	-944.00
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	2.17 Million	-
Other Financing Activities	-	-	-	-	150 Thousand	-65.75 Thousand
Accounts receivables	-	-	-	-	-	-
Accounts payables	-	-	-	-	355.91 Thousand	-78.48 Thousand
Inventory	-	-	-	-	-	-
Other working capital	-	-	-	-	-685.01 Thousand	644.03 Thousand
Cash at beginning of period	-	-	-	-	937.35 Thousand	2.68 Million
Cash at end of period	-	-	-	-	2.12 Million	937.35 Thousand
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	-	-	-	-	1.18 Million	-1.74 Million
Free Cash Flow	-	-	-	-	-1.14 Million	-1.67 Million